BioArctic AB (publ) (STO:BIOA.B)

BioArctic AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	999.69	-177.08	229.25	-11.18	-119.79	-68.52
Depreciation & Amortization	10.72	10.72	7.44	14.08	13.05	11.01
Loss (Gain) From Sale of Assets	-	-	-	-	-	0.21
Stock-Based Compensation	19.33	19.33	16.14	2.76	1.57	1.32
Other Operating Activities	63.43	-106.74	43.72	-62.21	-30.22	-62.92
Change in Accounts Receivable	-355.56	-105.23	-11.98	-2.41	-5.12	23.09
Change in Other Net Operating Assets	352.75	42.66	25.13	27.33	0.06	3.47
Operating Cash Flow	1,090	-316.33	309.69	-31.64	-140.46	-92.34
Capital Expenditures	-26.64	-26.64	-7.44	-12.75	-4.39	-12.47
Investment in Securities	232.27	232.27	-500.04	-0.02	-0.03	-0.05
Other Investing Activities	-795.56	0	-	0	0	-
Investing Cash Flow	-589.93	205.63	-507.49	-12.76	-4.41	-12.52
Long-Term Debt Repaid	-	-0.33	-0.92	-8.79	-7.39	-6.6
Net Debt Issued (Repaid)	-0.33	-0.33	-0.92	-8.79	-7.39	-6.6
Issuance of Common Stock	6.02	6.02	14.98	5.99	-	-
Other Financing Activities	21.94	-0	-0	-	-	-
Financing Cash Flow	27.63	5.69	14.06	-2.81	-7.39	-6.6
Foreign Exchange Rate Adjustments	-27.95	6.37	-10.09	4.19	0.72	-1.37
Miscellaneous Cash Flow Adjustments	0	-	-	-0	-	-
Net Cash Flow	500.12	-98.64	-193.82	-43.02	-151.54	-112.83
Free Cash Flow	1,064	-342.97	302.25	-44.38	-144.84	-104.81
Free Cash Flow Margin	55.51%	-133.27%	49.07%	-19.35%	-564.40%	-160.74%
Free Cash Flow Per Share	11.97	-3.87	3.42	-0.50	-1.65	-1.19
Cash Interest Paid	1.85	1.85	0.38	0.75	0.98	1.69
Cash Income Tax Paid	61.98	0.52	-0.16	-0.34	0.31	12.22
Levered Free Cash Flow	1,025	-290.3	210.92	-34.44	-91.07	-70.21
Unlevered Free Cash Flow	1,045	-290.3	211.13	-34.09	-90.55	-69.59
Change in Working Capital	-2.81	-62.57	13.15	24.91	-5.06	26.56

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.